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The role of measuring forced expiratory volume in one 
second in determining therapeutic changes made in an 
asthma clinic in general practice 
K. P. JONES 
University of Newcastle, Department of Primary Health Care, The Medical School, Framlington Place, 
Newcastle upon Tyne NE2 4HH 
In order to determine whether spirometric measurements in a primary care asthma clinic added useful 
information to symptom assessment and peak flow recordings, a retrospective audit of manual case records 
was conducted on patients attending an urban general practice asthma clinic. Sixty-three patients were 
identified in whom 108 increases in treatment at the clinic had been recorded and the associated determinants 
of these changes were extracted from their case notes. 
Therapeutic changes associated with the following determinants alone were only found in single instances: 
presence of or changes in symptoms, inhaler technique deficiency, forced expiratory volume in 1 s (FEV,) less 
than 75% of the predicted value and peak expiratory flow (PEF) rate less than 75% of the predicted value. In 
no instance did changes in FEV, or in PEF alone occur. The addition of spirometric measurements in this 
sample of patients only made an obvious difference to decision-making in four instances (4%). 
Therefore, the role of spirometers in the management of asthma in general practice needs further 
consideration and clarification on a wider scale before limited resources, whether in terms of time or money, 
are committed to their use. 
Introduction 
Nurse-run asthma care, usually in the form of 
clinics, has become much more common since the 
introduction of the new contract for general practice 
(1). Evidence regarding the effectiveness of such 
innovations is conflicting, with Charlton et al. show- 
ing benefits in their uncontrolled study (2) and other 
work in Southampton suggesting that the mere 
setting-up of this sort of proactive care does not 
appear to lead to sizeable reductions in morbidity (3). 
Providing extra nursing time and resources to help 
tackle the asthma problem should be a good thing on 
an ‘a priori’ basis, and better outcomes might result if 
more attention was paid to the protocols for clinics 
and priority given to tasks performed during patient 
visits. One such task is the measurement of lung 
function using spirometers. Theoretical evidence 
suggests that recording forced expiratory volume in 
1 s (FEV,) gives a more accurate and repeatable 
measure of airway obstruction than peak expiratory 
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flow (PEF) rate (4), and this measure has been used 
to document decreasing lung function in asthmatic 
subjects over a period of time (5). 
However, spirometers not only correlate poorly 
with mini-Wright peak flow meters (6) but also have 
a significant capital cost. This cost can only be 
justified if lung function measurements other than 
PEF rate can be shown to make a significant 
contribution to patient care. 
Therefore, this study aimed to examine all the 
therapeutic changes made within a clinic context in 
a sample of patients regularly attending the asthma 
clinic at Aldermoor Health Centre in Southampton. 
A spirometer is in regular use at this centre to 
determine whether spirometric measurements add 
additional useful information to that obtained from 
symptoms and PEF recordings. 
Materials and Methods 
The nurse-run asthma clinic has been running at 
Aldemoor Health Centre since early in 1987 and has 
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been organized according to the principles set out by 
Barnes and Pearson (7-9) by two nurses, both of 
whom have the diploma in asthma care, with medical 
back-up provided primarily by the author. The great 
majority of the spirometric and PEF recordings in 
the clinic are made by the nurses, but a few were 
made by the author in the early months of the clinic. 
All therapeutic changes were made after consulting 
one of the general practitioners within the practice. 
Patients were initially referred to the clinic by the 
general practitioners of the practice for a variety of 
tasks including assessment, diagnostic tests, checking 
of inhaler technique, education and routine follow- 
up. According to the protocol used in the clinic, 
spirometric measurements form part of both assess- 
ment and follow-up. Patients under the medical care 
of the author formed the majority of those seen in the 
nurse-run asthma clinic. 
The turbine spirometer (10) is used in the clinic to 
record FEV, and forced vital capacity, and the 
mini-Wright peak flow meter is used to record PEF 
rate. Spirometers are not otherwise in routine use by 
doctors during surgeries. Where therapeutic changes 
are made in the clinic after consultation with one of 
the general practitioners, a highlighted entry is made 
on the clinic continuation form. 
Retrospective clinic records were still being placed 
on the practice Abies-Meditel computer at the time of 
this study, but a computer search in October 1991 
found 133 patients in whom an initial asthma assess- 
ment had been conducted since the opening of the 
clinic. Fourteen of these patients had left the practice 
when the notes were drawn (their patient numbers 
having been reallocated to new people joining the 
practice list), and two were not actually asthmatic at 
all. The presence of these individuals in the search 
result probably represented keystroke errors on the 
practice computer. 
The available notes of the remaining patients 
were examined during a 3 day period and the 
following data extracted: code number, age in com- 
pleted years, age at diagnosis in completed years, 
smoking status and sex. For each therapeutic 
change recorded, the type of change was noted, (i.e. 
increase, decrease, no change in overall level of 
treatment), as was any change in device, and the 
therapeutic step made (e.g. start treatment with 
inhaled steroids). The following possible determi- 
nants of the change were also recorded: inhaler 
technique deficiencies, presence of or change in 
symptoms, change in FEV, or in PEF rate (in clinic 
or on home diary), and the presence of FEV, 
and/or PEF rate below 75% of the predicted value 
for the individual patient. 
Deficiency in inhaler technique was defined as any 
score below five in a previously published scoring 
system (11). A change in FEV, or PEF rate was 
defined arbitrarily as a 5% or greater change from the 
highest previously-measured value. Obviously, no 
change was possible if only one set of values were 
recorded. 
Patients were excluded from further analysis if they 
had been assessed without the subsequent introduc- 
tion of therapeutic changes at the clinic. Those 
changes which represented an increase in overall 
management (the majority) were then selected for 
detailed consideration. The possible determinants of 
the change were then examined for detectable inter- 
relations, with emphasis on those instances in which 
spirometric measures indicated a change in the 
absence of other factors. 
Results 
Of the 109 cases, 12 were asthmatic but had not 
had an assessment at the clinic and 34 had had no 
therapeutic change initiated in the clinic. The remain- 
ing 63 cases comprised 28 males and 35 females with 
a mean age of 34 years (SD 15 yr, range 1659 yr). 
The mean age at diagnosis of asthma was 21 years (SD 
16 yr, range O-53 yr). There were 108 therapeutic 
changes (or instances) in total within this group; 39 
patients had only one, 12 had two, six had three, 
three had four, and three had five. 
Bronchodilators were started in seven (7%) 
instances and changed in two (2%). Non-steroidal 
prophylactic agents were started in nine cases (8%) 
and inhaled steroids in 29 cases (27%), with a change 
in inhaled steroid in a further two (2%). Short-course 
oral steroids were given in 10 (9%) instances and no 
change in drug occurred in 50 (46%) (i.e. only the 
dose was altered). The nebulizer was not used in any 
instance. 
The inhaler device was changed in 20 (19%) 
instances. Changes in smoking status and in inhaler 
technique were poorly documented. The frequencies 
with which a number of possible determinants of 
change were individually associated with therapeutic 
changes are shown in Table 1. 
Therapeutic changes associated with the follow- 
ing possible determinants alone (i.e. in the absence 
of recorded change in other determinants) were 
only found in single instances: presence of or 
change in symptoms, inhaler technique deficiency, 
FEV, less than 75% of the predicted value and 
PEF rate less than 75% of the predicted value. In 
no instance did recorded changes in FEV, or in 
PEF rate alone occur. PEF rate was always 
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Table 1 Frequencies of possible determinants of therapeutic changes in a nurse-run asthma 
clinic (n = 108) 




Peak expiratory flow rate 
Peak expiratory flow rate 
(% predicted)* 
Home peak expiratory flow 
rate diary 
Inhaler technique deficienciest 
Symptoms 
33 (31) 50 (46) 25 (23) 
54 (50) 28 (26) 26 (24) 
34 (32) 66 (61) 8 (7) 
38 (35) 56 (52) 14 (13) 
7 (7) 2 (2) 99 (92) 
25 (23) 37 (34) 45 (42) 
73 (68) 15 (14) 20 (19) 
*Change=<75%, no change=>75%. tChange=score ~5, no change=5. 
measured when FEV, was measured, as per clinic 
protocol, but the converse was not true. Changes 
in FEV, were found without accompanying PEF 
rate changes in 12 instances (1 lo/o), but in only two 
of these instances were symptom changes not 
recorded. Changes in PEF were found without any 
record of FEV, in seven instances (6%) and 
without a change in this variable in a further six 
(6%) instances. 
A PEF rate less than 75% of the predicted value 
was found in eight instances (7%), where no record of 
FEV, was made, and in three instances (3%) where 
no similar reduction was documented. A FEV, less 
than 75% of the predicted value was found in only 
four instances (4%), where no similar reduction 
in PEF rate was documented, and in two of these, 
a change in PEF rate from previous values was 
present. 
Discussion 
It is clear from the clinic audit that all possible 
determinants of a therapeutic change were not 
recorded from several patient visits to the asthma 
clinic which resulted in treatment alterations. Fur- 
thermore, no single possible determinant was con- 
sistently recorded in all instances - though change 
or persistence of symptoms in 68% of instances 
was much higher than FEV, less than 75% in 50% 
of instances and similar PEF reduction in 35% of 
instances. The reasons behind these omissions are not 
certain in retrospect, but may have included a clinical 
perception by the nurses that certain determinants 
were not of importance in particular circumstances, 
despite being part of the clinic protocol. The very low 
record of usage of home PEF diaries is likely to have 
changed since the study was conducted, with greater 
use of self-management (12,13) now that meters are 
prescribable. 
The results also show that the addition of spiro- 
metric measurements in this sample of patients only 
appeared to make a unique contribution to clinical 
decision-making in four instances (4%). However, the 
number of instances with missing information must 
place a considerable note of caution after this con- 
clusion. FEV, was not recorded much within the 
clinic (and not at all by the practice doctors outside 
the clinic). When changes or reductions in FEV, were 
documented, they were just one element of the 
history and examination process. Furthermore, the 
definitions of change or reduction in both FEV, and 
PEF rate were devised for this study and do not form 
part of either the clinic protocol or the individual 
plans of doctors. Spirometry may have made a 
contribution to decision-making in the presence of 
other determinants of change - this possibility could 
not be assessed from an observational study of 
clinical records. 
What can be confidently said is that the purchasing 
and use of spirometers in primary care without very 
careful consideration and agreement about their 
place in a practice management plan for asthma, 
seem unlikely to bring about better asthma care nor 
to be worth the initial capital outlay or nursing time. 
Within the practice studied, the instruments were 
primarily purchased for research purposes, but it is 
true to say that they were used in the clinic because 
they were available and not because of a clear 
perception of possible benefit. 
The clinic audit focused on the role of spirometers 
as currently used in the follow-up of asthma. Our 
hospital colleagues may well argue that the more 
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important role of this type of instrument lies in the 
diagnosis of the disease. This too is questionable in 
general practice. 
Diagnosis of asthma has been hampered for far too 
long by a lack of awareness of its possibility in 
respiratory consultations or a reluctance to make the 
diagnosis (14-17), but there is evidence that this is 
beginning to improve (18). The careful use of PEF 
meters in reversibility tests, exercise tests, home 
diaries and trials of treatment is likely to be all that is 
required in diagnosis, provided that care is taken 
regarding which type of device is used regularly 
(19,20) and how often they are cleaned and replaced 
(21). Recent evidence by Dekker et al. has shown that 
a 60 1 min - ’ increase in PEF rate during reversibility 
testing predicts a diagnostic change in FEV, with a 
clinically acceptable level of accuracy (22). There is, 
however, recent evidence that all the currently avail- 
able and prescribable mini-peak flow meters show 
significant errors, particularly in over-reading at PEF 
rates below 350 1 min ~ ’ (23). This requires further 
investigation and an agreed decision on the question 
of resealing meters (24) before there can be complete 
confidence in the use of such meters, especially in 
self-management. 
Asthma is a disease eminently suited to manage- 
ment in general practice, since no great technology is 
needed. Limited resources, whether in terms of time 
or money, are best directed to careful development of 
a management plan for asthma with emphasis on 
organizational detail, rather than machinery in the 
first instance. 
This small scale study is not sufficient in itself to 
demonstrate the proper role of spirometry in primary 
care, but it does indicate the need for a larger scale 
investigation to address this question more defini- 
tively. The most cost-effective format for regular 
review of patients with asthma in general practice still 
needs to be defined. 
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